Skip to main content
رجوع
Watch Compare

JRSIS HEALTH CARE Corp

جودة البيانات: 100%
JRSS
OTC Services Health Services
KWD 0.01
KWD 0.00 (0.00%)
القيمة السوقية: 837,526.0
السعر
KWD 0.01
القيمة السوقية
837,526.0
نطاق اليوم
—
نطاق 52 أسبوعًا
—
حجم التداول
—
فتح —
متوسط 50 يوم / 200 يوم
—
متوسط 50 يوم / 200 يوم
—

Quick Summary

النقاط الرئيسية

Earnings declined -103.47% over the past year
Negative free cash flow of -244,523.0
Capital efficient — spends only 0.94% of revenue on capex

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)3782.57%
Earnings (1Y)-103.47%
FCF Growth (3Y)-70.52%

الجودة

Return on Equity
N/A
ROIC-21.42%
Net Margin-3.67%
Op. Margin-7.01%

الأمان

Debt / Equity
N/A
Current Ratio0.78
Interest Coverage-3.93

التقييم

PE (TTM)
-4.83
أقل من متوسط القطاع (-1.18)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Services (506 نظير)
المقياس السهم وسيط القطاع
P/E -4.8 -1.2
P/B — 1.4
ROE % — -15.8
Net Margin % -3.7 -18.3
Rev Growth 5Y % — 4.2
D/E — 0.4

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

تقديرات الأرباح

لا تتوفر تقديرات مستقبلية

All Fundamental Metrics
Growth
Revenue Growth (1Y) 3782.57% Revenue Growth (3Y) -72.07%
Earnings Growth (1Y) -103.47% Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 4.73 M Net Income (TTM) -173,547.0
ROE N/A ROA -8.29%
Gross Margin 15.94% Operating Margin -7.01%
Net Margin -3.67% Free Cash Flow (TTM) -244,523.0
ROIC -21.42% FCF Growth (3Y) -70.52%
Safety
Debt / Equity N/A Current Ratio 0.78
Interest Coverage -3.93 Asset Turnover 2.26
Working Capital -512,474 Tangible Book Value -438,740
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4.83 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0.18
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -29.20%
Market Cap 837,526.0 Enterprise Value 2.18 M
Per Share
EPS (Diluted TTM) 0.05 Revenue / Share 0.06
FCF / Share 0.00 OCF / Share 0.00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.94% FCF Conversion 140.90%
SBC-Adj. FCF -326,345 Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2023 FY2022 FY2021 FY2020 FY2019
Revenue 3.46 M 89,166.0 44.39 M — —
Net Income -80,912.0 2.33 M 3.19 M 2.68 M 888,061.0
EPS (Diluted) 0.00 -0.75 0.12 0.15 0.05
Gross Profit 483,051.0 — — — —
Operating Income -188,598.0 -325,889.0 4.10 M 5.59 M 4.67 M
EBITDA — — — — —
R&D Expenses 189,266.0 — — — —
SG&A Expenses — — — — —
D&A 53,815.0 5,796.0 — 2.70 M 2.21 M
Interest Expense 56,443.0 — 1.38 M 1.14 M 1.11 M
Income Tax 8,975.0 — 1.18 M 1.37 M 657,699.0

Balance Sheet

Annual, most recent first
Metric FY2023 FY2022 FY2021 FY2020 FY2019
Total Assets 2.14 M 855,977.0 75.69 M 58.80 M 51.63 M
Total Liabilities 2.31 M 44,661.0 42.59 M 29.96 M 28.64 M
Shareholders' Equity -137,406.0 811,316.0 22.07 M 19.04 M 14.82 M
Total Debt 24,950.0 — — — —
Cash & Equivalents — 58,616.0 855,971.0 844,827.0 1.97 M
Current Assets 1.83 M 798,850.0 13.87 M 7.88 M 9.51 M
Current Liabilities 2.28 M 43,231.0 17.60 M 11.76 M 10.92 M